Ignite Creation Date:
2025-12-24 @ 2:04 PM
Ignite Modification Date:
2026-01-01 @ 12:33 AM
Study NCT ID:
NCT01544595
Status:
COMPLETED
Last Update Posted:
2018-12-20
First Post:
2012-02-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06-19
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-26
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-28
First Submit QC Date:
None
Study First Post Date:
2012-03-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-06-25
Results First Submit QC Date:
None
Results First Post Date:
2018-12-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-27
Last Update Post Date:
2018-12-20
Last Update Post Date Type:
ACTUAL